Argenx SE
Overview
Argenx SE is a global biotechnology company developing a pipeline of antibody-based therapies for the treatment of severe autoimmune diseases and cancer. The company leverages its suite of cutting-edge antibody technologies to engage novel targets and create immunotherapeutic solutions.
Therapeutic areas
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to Argenx SE in our records. PharmaTek screens the full directory against live FDA enforcement data.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.